Previous 10 | Next 10 |
2023-09-12 07:48:40 ET More on Horizon Therapeutics Seeking Alpha’s Quant Rating on Horizon Therapeutics Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion? Improved Outlook For Horizon Therapeutics And Amgen Irish High Court hearing ...
2023-09-07 11:35:48 ET Summary Amgen could report great quarterly results with revenue, operating income and EPS growing with a solid pace. The stock is undervalued in my opinion and Amgen could be seen as a good investment. However, I think the Horizon acquisition was not the...
2023-09-06 14:40:51 ET Summary On August 3, Amgen released its financial report for the second quarter of 2023, demonstrating a significant improvement in its financial position. Amgen's revenue for the second quarter of 2023 was $6.99 billion, 14.4% more than the previous quarter...
2023-09-01 11:59:09 ET Shares of Horizon Therapeutics PLC (NASDAQ: HZNP) are trading materially up today after the FTC allowed Amgen Inc (NASDAQ: AMGN) to move forward with its $27.8 billion acquisition of the biopharmaceutical company. FTC imposed restrictions on Amgen-Horizon deal...
2023-09-01 09:22:00 ET U.S. stock index futures on Friday were higher , after the latest nonfarm payrolls report showed a rise in the unemployment rate, adding onto earlier indicators this week that have showed a cooling in the labor market. The jobless rate ticked up to 3.8% in August ...
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION PR Newswire THOUSAND OAKS, Calif. and DUBLIN , Sept. 1, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry in...
Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen’s acquisition of...
2023-09-01 08:53:19 ET More on Amgen, Horizon Therapeutics, etc. Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion? Improved Outlook For Horizon Therapeutics And Amgen Amgen Is Back! Amgen Gives You Growth, Dividend Growth, And Value ...
2023-08-31 07:53:00 ET Are you a biotech investor who feels left behind? You're not alone. The broad Nasdaq Composite index has gained 13.7% since mid-May, but the Nasdaq Biotechnology index fell slightly over the same time frame. The reason that biotech industry stocks have bee...
2023-08-30 18:10:35 ET More on Horizon Therapeutics Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion? Improved Outlook For Horizon Therapeutics And Amgen Biggest stock movers today: Hawaiian Electric, RPT Realty, VinFast Auto and more Hori...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...